Clinical and demographic predictors of the need for pharmacotherapy in neonatal abstinence syndrome
ObjectiveDevelopment and validation of a clinical prediction model for receipt of pharmacotherapy for Neonatal Abstinence Syndrome (NAS).Study designData from three cohorts included in- utero opioid exposed neonates ≥37 weeks gestation. Primary outcome was the receipt of pharmacotherapy utilizing a...
Saved in:
| Main Authors: | Shawana Bibi, Rachana Singh, Janis L. Breeze, Jason Nelson, Walter K. Kraft, Jonathan M. Davis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1527276/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nursing professionals’ knowledge in the management of newborns with neonatal abstinence syndrome
by: Laís Lima Silva, et al.
Published: (2023-09-01) -
Impact of a qualitative assessment approach for neonatal abstinence syndrome management: experience of a European reference center
by: Mariana Cortez Ferreira, et al.
Published: (2024-10-01) -
GENETIC PREDICTORS OF SEVERITY AND EFFICACY OF COVID-19 PHARMACOTHERAPY
by: I. N. Shishimorov, et al.
Published: (2021-08-01) -
Abstinence-based treatment of comorbid eating disorders and ultra-processed food addiction
by: Susan Peirce Thompson, et al.
Published: (2025-07-01) -
Combination of Drugs in the Treatment of Alcohol Use Disorder: A Meta-Analysis and Meta-Regression Study
by: João Vitor Guimarães Mandaji, et al.
Published: (2025-05-01)